• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

1
results for

"Prapaporn Pornsuriyasak"

Filter

Article category

Keywords

Publication year

Authors

Funded articles

"Prapaporn Pornsuriyasak"

Original Article
Effects of Oral Procaterol for Postinfectious Cough in Adults: Single-Centre, Randomized Double-Blind, Placebo-Controlled Trial
Prapaporn Pornsuriyasak, Sasivimol Rattanasiri, Nattawut Unwanatham, Theerasuk Kawamatawong, Pennapa Jankum, Ammarin Thakkinstian
Korean J Fam Med 2021;42(2):159-165.   Published online May 14, 2020
DOI: https://doi.org/10.4082/kjfm.19.0118
Background
Persistent cough following an upper respiratory tract infection (URTI) is common in clinical practice. We investigated the effects of procaterol on cough-specific quality of life (QoL) and peripheral-airway function among adults suffering from postinfectious cough (PIC).
Methods
This was a prospective, randomized, double-blinded placebo-controlled trial (NCT 02349919) conducted at a university hospital. Seventy-four non-asthmatic adults who had persistent post-URTI cough for ≥3 weeks were assessed by a physical examination, chest/paranasal sinus radiographs, spirometry, and impulse oscillometry (IOS) and were allocated to receive procaterol or placebo for 4 weeks. The Thai version of the Leicester Cough Questionnaire (LCQ-T), spirometry and IOS were assessed at baseline, 2 weeks, and 4 weeks.
Results
Mean LCQ-T total scores for the procaterol group (10.8) and placebo group (10.9) at baseline were not significantly different (P=0.821). After adjustment for baseline Borg Cough Scale score and post-nasal drip, the mean between-group difference was not significant for LCQ-T total score (-1.26; 95% confidence interval [CI], -2.69 to 0.17), physical domain score (-0.35; 95% CI, -0.76 to 0.06), psychological domain score (-0.53; 95% CI, -1.06 to 0.01), or social domain score (-0.38; 95% CI, -0.92 to 0.16). Large improvements in LCQ-T total score were reported in both groups after 2 weeks (procaterol, 4.21±2.73; placebo, 5.34±3.2), and 4 weeks (procaterol, 5.94±3.68; placebo, 7.07±3.44). No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks.
Conclusion
Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function.

Citations

Citations to this article as recorded by  
  • Post-infectious cough in patients with obesity: an observational study
    Yin Xian, Yuan Zhang, Xiangxin Kong, Ke Song
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Window of opportunity for respiratory oscillometry: A review of recent research
    Sabina Kostorz-Nosal, Dariusz Jastrzębski, Anna Błach, Szymon Skoczyński
    Respiratory Physiology & Neurobiology.2023; 316: 104135.     CrossRef
  • 7,489 View
  • 166 Download
  • 3 Web of Science
  • 2 Crossref
TOP